These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 29663335

  • 1. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A, Ilvento L, Rizzi R, Doccini V, Leo MC, Pugi A, De Masi S, Guerrini R.
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study.
    Rosati A, Boncristiano A, Doccini V, Pugi A, Pisano T, Lenge M, De Masi S, Guerrini R.
    Epilepsia; 2019 Nov; 60(11):2255-2262. PubMed ID: 31630399
    [Abstract] [Full Text] [Related]

  • 3. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients.
    Böttcher S, Lutz MT, Mayer T.
    Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A, D'Souza W, Hepworth G, Lawn N, Cook M, Nikpour A.
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [Abstract] [Full Text] [Related]

  • 5. Use of lacosamide in children: experience of a tertiary medical care center in Brazil.
    Romão TT, Angelim AIM, Prado HJPD, Goes FV, Pires MEP, Fontana RDS, Pires LC, Fernandes AR, D'Andrea-Meira I.
    Arq Neuropsiquiatr; 2022 Nov; 80(11):1090-1096. PubMed ID: 36577407
    [Abstract] [Full Text] [Related]

  • 6. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
    Zhou R, Qu R, Liu M, Huang DP, Zhou JY, Chen Y, Chen XQ.
    Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study.
    Zhao T, Yu LH, Zhang HL, Yu J, Feng J, Wang TT, Sun Y, Li HJ.
    BMC Pediatr; 2023 May 20; 23(1):249. PubMed ID: 37210552
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy, safety, and tolerability, including behavior and executive functioning, during adjunctive lacosamide treatment in pediatric patients with uncontrolled epilepsy.
    Farkas MK, Makedonska I, Beller C, Bourikas D, de la Loge C, Dimova S, Floricel F, McClung C, Moseley B, Therriault S, Pina-Garza JE.
    Epilepsy Behav; 2024 Oct 20; 159():109989. PubMed ID: 39216464
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R, Ley M, Molins A, Toledo M, Sansa G, Bertol V, Becerra JL, Carreño M, Mauri JÁ.
    Epilepsy Behav; 2018 Feb 20; 79():87-92. PubMed ID: 29253680
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
    Kurth C, Kockelmann E, Steinhoff BJ.
    Seizure; 2017 Feb 20; 45():47-51. PubMed ID: 27915111
    [Abstract] [Full Text] [Related]

  • 14. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
    Yildiz EP, Ozkan MU, Bektas G, Uzunhan TA, Aydinli N, Caliskan M, Ozmen M.
    Childs Nerv Syst; 2017 Nov 20; 33(11):2023-2027. PubMed ID: 28884208
    [Abstract] [Full Text] [Related]

  • 15. Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study.
    Ishikawa N, Eguchi Y, Izumo H, Tateishi Y, Tani H, Kobayashi Y, Okada S.
    Epilepsy Behav; 2022 Apr 20; 129():108614. PubMed ID: 35203014
    [Abstract] [Full Text] [Related]

  • 16. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
    Muñoz-Lopetegi A, López-González FJ, Rodríguez-Osorio X, Pato Pato A, Bellas Lamas P, Abella-Corral J, Castro Vilanova MD, Garea MJ, Gil López JA, Ruiz-Martínez J, Poza JJ.
    Epilepsy Res; 2018 Sep 20; 145():51-54. PubMed ID: 29890341
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
    Talha Özgün O, Kandemir Yılmaz M, Mert Atmaca M, Keskin Güler S, Buluş E, Duman A, Çelebi Ö, Gürses C.
    Epilepsy Behav; 2023 Aug 20; 145():109355. PubMed ID: 37473655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.